Mainz Biomed (MYNZ) Cash & Equivalents (2020 - 2025)
Historic Cash & Equivalents for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to $1.9 million.
- Mainz Biomed's Cash & Equivalents rose 9545.3% to $1.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 million, marking a year-over-year increase of 9545.3%. This contributed to the annual value of $6.2 million for FY2024, which is 1181.25% down from last year.
- Latest data reveals that Mainz Biomed reported Cash & Equivalents of $1.9 million as of Q2 2025, which was up 9545.3% from $6.2 million recorded in Q4 2024.
- Mainz Biomed's 5-year Cash & Equivalents high stood at $17.1 million for Q4 2022, and its period low was $977764.0 during Q2 2024.
- Moreover, its 5-year median value for Cash & Equivalents was $8.7 million (2021), whereas its average is $9.3 million.
- Per our database at Business Quant, Mainz Biomed's Cash & Equivalents skyrocketed by 702057.14% in 2021 and then tumbled by 9429.6% in 2024.
- Mainz Biomed's Cash & Equivalents (Quarter) stood at $8.7 million in 2021, then surged by 96.41% to $17.1 million in 2022, then plummeted by 58.75% to $7.1 million in 2023, then decreased by 11.81% to $6.2 million in 2024, then crashed by 69.35% to $1.9 million in 2025.
- Its Cash & Equivalents stands at $1.9 million for Q2 2025, versus $6.2 million for Q4 2024 and $977764.0 for Q2 2024.